Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1977 Sep;17(3):497–503. doi: 10.1128/iai.17.3.497-503.1977

Production of colicin V in vitro and in vivo and observations on its effects in experimental animals.

G Ozanne, L G Mathieu, J P Baril
PMCID: PMC421151  PMID: 332624

Abstract

In recent years, a possible relationship between pathogenicity and colicinogeny in some Escherichia coli strains responsible for gastrointestinal infection and bacteremia in man and animals has been inferred. Using enterotoxigen-negative, colicin V-producing E. coli strains, we have (i) elaborated a simple in vitro method for producing greater yields of colicin V free of bacterial cells and large, non-dialyzable molecules; (ii) detected the presence of the bacteriocin in peritoneal fluids of moribund mice injected intraperitoneally 18 h previously with colicin V-producing strains (in these mice, Col V+ exconjugants survived and multiplied more extensively than the Col V- recipient strains from which they were derived; and (iii) observed an increased vascular permeability and inflammatory response in rabbits and guinea pigs when a culture supernatant demonstrating colicin activity was injected intradermally. The vascular response obtained after the injection of either a colicin V-containing dialysate alone or that of a trypsinized colicin-containing supernatant was always smaller than when the colicin V-active supernatant was injected. An enterotoxin-free dialysate containing colicin V also increased markedly in rabbits and guinea pigs the mild inflammatory reaction that occurred in the skin when purified endotoxin was injected subcutaneously in microgram doses. Our results are consistent with the hypothesis that colicin V may act as a virulence factor in some E. coli strains.

Full text

PDF

Images in this article

499Image
on p.499
500Image
on p.500
501Image
on p.501

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRAUDE A. I., SIEMIENSKI J. S. THE INFLUENCE OF BACTERIOCINS ON RESISTANCE TO INFECTION BY GRAM-NEGATIVE BACTERIA. I. THE EFFECT OF COLICIN ON BACTERICIDAL POWER OF BLOOD. J Clin Invest. 1965 May;44:849–859. doi: 10.1172/JCI105197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Evans D. J., Jr, Evans D. G., Gorbach S. L. Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man. Infect Immun. 1973 Nov;8(5):725–730. doi: 10.1128/iai.8.5.725-730.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hardy K. G. Colicinogeny and related phenomena. Bacteriol Rev. 1975 Dec;39(4):464–515. doi: 10.1128/br.39.4.464-515.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Lavoie M., Mathieu L. G., Charron-Allie L. Inhibition of colicin production by fermentable sugars. Can J Microbiol. 1974 Feb;20(2):269–272. doi: 10.1139/m74-044. [DOI] [PubMed] [Google Scholar]
  5. Lavoie M., Mathieu L. G. Isolation and partial characterization of an Escherichia coli mutant resistant to colicin A. Can J Microbiol. 1975 Oct;21(10):1595–1601. doi: 10.1139/m75-233. [DOI] [PubMed] [Google Scholar]
  6. Mathieu L. G., De Repentigny J., Turgeon S., Sonea S. Infection in mouse peritoneal cavity with a pyrimidine-requiring mutant and naturally occurring Staphylococcus aureus strains. J Bacteriol. 1967 Jul;94(1):13–18. doi: 10.1128/jb.94.1.13-18.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Mathieu L. G., Legault-Hetu D. Decreased sensitivity to polymyxin B in colicin K tolerant cells of Escherichia coli K-12 in the presence of colicin K. Can J Microbiol. 1973 Mar;19(3):345–351. doi: 10.1139/m73-057. [DOI] [PubMed] [Google Scholar]
  8. Nomura M. Colicins and related bacteriocins. Annu Rev Microbiol. 1967;21:257–284. doi: 10.1146/annurev.mi.21.100167.001353. [DOI] [PubMed] [Google Scholar]
  9. Sack R. B. Human diarrheal disease caused by enterotoxigenic Escherichia coli. Annu Rev Microbiol. 1975;29:333–353. doi: 10.1146/annurev.mi.29.100175.002001. [DOI] [PubMed] [Google Scholar]
  10. Smarda J., Ebringer L., Mach J. The effect of colicin E2 on the flagellate Euglena gracilis. J Gen Microbiol. 1975 Feb;86(2):363–366. doi: 10.1099/00221287-86-2-363. [DOI] [PubMed] [Google Scholar]
  11. Smith H. W. A search for transmissible pathogenic characters in invasive strains of Escherichia coli: the discovery of a plasmid-controlled toxin and a plasmid-controlled lethal character closely associated, or identical, with colicine V. J Gen Microbiol. 1974 Jul;83(0):95–111. doi: 10.1099/00221287-83-1-95. [DOI] [PubMed] [Google Scholar]
  12. Smith H. W., Huggins M. B. Further observations on the association of the colicine V plasmid of Escherichia coli with pathogenicity and with survival in the alimentary tract. J Gen Microbiol. 1976 Feb;92(2):335–350. doi: 10.1099/00221287-92-2-335. [DOI] [PubMed] [Google Scholar]
  13. Tagg J. R., Dajani A. S., Wannamaker L. W. Bacteriocins of gram-positive bacteria. Bacteriol Rev. 1976 Sep;40(3):722–756. doi: 10.1128/br.40.3.722-756.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Whipp S. C., Moon H. W., Lyon N. C. Heat-stable Escherichia coli enterotoxin production in vivo. Infect Immun. 1975 Aug;12(2):240–244. doi: 10.1128/iai.12.2.240-244.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES